A Theoretical Analysis of the Synergy of Amyloid and Tau in Alzheimer's Disease

J Alzheimers Dis. 2016 Apr 19;52(4):1461-70. doi: 10.3233/JAD-151206.

Abstract

Amyloid plaques and Tau protein neurofibrillary tangles are considered the two most important pathogenic factors in Alzheimer's disease. The prevailing amyloid cascade hypothesis suggests that amyloid-β (Aβ) elevation induces downstream Tau hyperphosphorylation and aggregation, synaptic dysfunction, and neuronal loss that ultimately results in cognitive impairment. Alternatively, the dual-pathway hypothesis suggests that Aβ and abnormal Tau are two independent factors that exert synergistic effects on synaptic dysfunction and neuronal loss. We hypothesize that the intrinsic interaction of Aβ and Tau would better predict cognitive impairment. Herein, we propose an Aβ-Tau interactive model based on a review of the medical literature, mathematic modeling, and analysis of our clinicopathological data.

Keywords: Alzheimer’s disease; Tau; amyloid plaque; neurofibrillary tangle.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged, 80 and over
  • Alzheimer Disease / etiology*
  • Alzheimer Disease / metabolism
  • Amyloid / metabolism
  • Amyloid / physiology
  • Amyloid beta-Peptides / metabolism
  • Amyloid beta-Peptides / physiology
  • Brain / metabolism
  • Brain / physiopathology
  • Case-Control Studies
  • Cognitive Dysfunction / etiology
  • Cognitive Dysfunction / metabolism
  • Female
  • Humans
  • Male
  • Models, Biological
  • Neurons / metabolism
  • Neurons / physiology
  • Plaque, Amyloid / metabolism*
  • Plaque, Amyloid / physiopathology
  • Synapses / metabolism
  • Synapses / physiology
  • tau Proteins / metabolism*
  • tau Proteins / physiology

Substances

  • Amyloid
  • Amyloid beta-Peptides
  • tau Proteins